AAM
BSX icon

Advisors Asset Management’s Boston Scientific BSX Stock Holding History

Advisors Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.66M Sell
42,354
-102
-0.2% -$8.16K 0.04% 515
2025
Q4 		$4.05M Buy
42,456
+232
+0.5% +$22.7K 0.07% 376
2025
Q3 		$4.12M Buy
42,224
+192
+0.5% +$19.9K 0.07% 374
2025
Q2 		$4.51M Buy
42,032
+6,199
+17% +$627K 0.08% 330
2025
Q1 		$3.61M Buy
35,833
+1,863
+5% +$188K 0.07% 394
2024
Q4 		$3.03M Buy
33,970
+9,910
+41% +$872K 0.06% 457
2024
Q3 		$2.02M Buy
24,060
+4,233
+21% +$334K 0.04% 551
2024
Q2 		$1.53M Buy
19,827
+12,283
+163% +$899K 0.03% 616
2024
Q1 		$517K Buy
7,544
+2,361
+46% +$152K 0.01% 899
2023
Q4 		$300K Buy
+5,183
New +$277K 0.01% 1040
2022
Q2 		– Sell
-4,208
Closed -$186K – 1495
2022
Q1 		$186K Sell
4,208
-43,771
-91% -$1.9M ﹤0.01% 1242
2021
Q4 		$2.04M Sell
47,979
-53,542
-53% -$2.25M 0.03% 598
2021
Q3 		$4.41M Sell
101,521
-48,456
-32% -$2.14M 0.07% 304
2021
Q2 		$6.41M Sell
149,977
-39,349
-21% -$1.66M 0.09% 212
2021
Q1 		$7.32M Sell
189,326
-49,251
-21% -$1.86M 0.11% 175
2020
Q4 		$8.58M Buy
238,577
+9,030
+4% +$325K 0.14% 128
2020
Q3 		$8.77M Buy
229,547
+10,255
+5% +$395K 0.16% 118
2020
Q2 		$7.7M Buy
219,292
+17,111
+8% +$616K 0.15% 131
2020
Q1 		$6.6M Sell
202,181
-3,046
-1% -$119K 0.16% 135
2019
Q4 		$9.28M Buy
205,227
+33,909
+20% +$1.42M 0.16% 143
2019
Q3 		$6.97M Buy
171,318
+45,558
+36% +$1.93M 0.13% 190
2019
Q2 		$5.41M Buy
125,760
+51,040
+68% +$1.96M 0.1% 250
2019
Q1 		$2.87M Buy
74,720
+38,864
+108% +$1.48M 0.05% 426
2018
Q4 		$1.27M Buy
+35,856
New +$1.3M 0.03% 680
2017
Q1 		– Sell
-5,675
Closed -$123K – 1580
2016
Q4 		$123K Sell
5,675
-200
-3% -$4.36K ﹤0.01% 1463
2016
Q3 		$140K Sell
5,875
-300
-5% -$7.16K ﹤0.01% 1423
2016
Q2 		$144K Buy
+6,175
New +$134K ﹤0.01% 1418
2016
Q1 		– Sell
-6,475
Closed -$119K – 1810
2015
Q4 		$119K Hold
6,475
– – ﹤0.01% 1509
2015
Q3 		$106K Sell
6,475
-400
-6% -$6.84K ﹤0.01% 1506
2015
Q2 		$122K Buy
6,875
+100
+1% +$1.79K ﹤0.01% 1489
2015
Q1 		$120K Sell
6,775
-200
-3% -$3.16K ﹤0.01% 1468
2014
Q4 		$92K Sell
6,975
-100
-1% -$1.28K ﹤0.01% 1523
2014
Q3 		$84K Sell
7,075
-200
-3% -$2.52K ﹤0.01% 1491
2014
Q2 		$93K Sell
7,275
-100
-1% -$1.3K ﹤0.01% 1481
2014
Q1 		$100K Sell
7,375
-100
-1% -$1.31K ﹤0.01% 1440
2013
Q4 		$90K Sell
7,475
-400
-5% -$4.73K ﹤0.01% 1440
2013
Q3 		$92K Sell
7,875
-300
-4% -$3.25K ﹤0.01% 1373
2013
Q2 		$76K Buy
+8,175
New +$69.3K ﹤0.01% 1388

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisors Asset Management's BSX Position: Q1 2026 in Review

Advisors Asset Management reduced its Boston Scientific (BSX) stake by 0.24% in Q1 2026, selling an estimated $8.16K and leaving 42,354 shares worth $2.66M. The position accounts for 0.04% of the portfolio, ranked #515.

Advisors Asset Management first reported a position in BSX in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.28M in Q4 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Advisors Asset Management held 42,354 shares of Boston Scientific worth $2.66M as of Q1 2026.
  • Advisors Asset Management sold 102 Boston Scientific shares in Q1 2026, an estimated $8.16K.
  • Boston Scientific made up 0.04% of Advisors Asset Management's portfolio in Q1 2026, its #515 holding.
  • Advisors Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 38 quarters since.
  • Advisors Asset Management's Boston Scientific position peaked at $9.28M in Q4 2019.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.